 | • レポートコード：GIR201101664 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、バイオシミラー薬品の世界市場を調査対象にし、バイオシミラー薬品の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（注射、錠剤、その他）、用途別分析（強直性脊椎炎、腫瘍、関節リウマチ、心血管、その他用途）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Amgen、CP Guojian Pharma、Eli Lilly、Novartis、Biotech Pharma ・メーカー別販売量、売上、市場シェア ・バイオシミラー薬品の地域別市場分析 ・バイオシミラー薬品の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・バイオシミラー薬品のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・バイオシミラー薬品のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・バイオシミラー薬品の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・バイオシミラー薬品の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・バイオシミラー薬品の種類別市場規模2015-2020：注射、錠剤、その他 ・バイオシミラー薬品の用途別市場規模2015-2020：強直性脊椎炎、腫瘍、関節リウマチ、心血管、その他用途 ・バイオシミラー薬品の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Biosimilar Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Biosimilar Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Biosimilar Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biosimilar Drug market has been segmented into
Injection
Tablets
Other Types
By Application, Biosimilar Drug has been segmented into:
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimilar Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimilar Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimilar Drug market.
The report offers in-depth assessment of the growth and other aspects of the Biosimilar Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Biosimilar Drug Market Share Analysis
Biosimilar Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biosimilar Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimilar Drug sales, revenue and market share for each player covered in this report.
The major players covered in Biosimilar Drug are:
Amgen
CP Guojian Pharma
Eli Lilly
Novartis
Biotech Pharma
Among other players domestic and global, Biosimilar Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilar Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilar Drug, with price, sales, revenue and global market share of Biosimilar Drug in 2018 and 2019.
Chapter 3, the Biosimilar Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biosimilar Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biosimilar Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Biosimilar Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilar Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilar Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Overview of Global Biosimilar Drug Market
1.4.1 Global Biosimilar Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 CP Guojian Pharma
2.2.1 CP Guojian Pharma Details
2.2.2 CP Guojian Pharma Major Business
2.2.3 CP Guojian Pharma SWOT Analysis
2.2.4 CP Guojian Pharma Product and Services
2.2.5 CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biotech Pharma
2.5.1 Biotech Pharma Details
2.5.2 Biotech Pharma Major Business
2.5.3 Biotech Pharma SWOT Analysis
2.5.4 Biotech Pharma Product and Services
2.5.5 Biotech Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biosimilar Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biosimilar Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biosimilar Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Biosimilar Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biosimilar Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Biosimilar Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biosimilar Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Biosimilar Drug Sales and Growth Rate (2015-2020)
4.3 Europe Biosimilar Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biosimilar Drug Sales and Growth Rate (2015-2020)
4.5 South America Biosimilar Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biosimilar Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biosimilar Drug Sales, Revenue and Market Share by Country
5.1.1 North America Biosimilar Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Biosimilar Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Biosimilar Drug Sales and Growth Rate (2015-2020)
5.3 Canada Biosimilar Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Biosimilar Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biosimilar Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Biosimilar Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biosimilar Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Biosimilar Drug Sales and Growth Rate (2015-2020)
6.3 UK Biosimilar Drug Sales and Growth Rate (2015-2020)
6.4 France Biosimilar Drug Sales and Growth Rate (2015-2020)
6.5 Russia Biosimilar Drug Sales and Growth Rate (2015-2020)
6.6 Italy Biosimilar Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biosimilar Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biosimilar Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biosimilar Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Biosimilar Drug Sales and Growth Rate (2015-2020)
7.3 Japan Biosimilar Drug Sales and Growth Rate (2015-2020)
7.4 Korea Biosimilar Drug Sales and Growth Rate (2015-2020)
7.5 India Biosimilar Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biosimilar Drug Sales and Growth Rate (2015-2020)
7.7 Australia Biosimilar Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biosimilar Drug Sales, Revenue and Market Share by Country
8.1.1 South America Biosimilar Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Biosimilar Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biosimilar Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Biosimilar Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biosimilar Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biosimilar Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biosimilar Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biosimilar Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Biosimilar Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Biosimilar Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Biosimilar Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biosimilar Drug Sales and Market Share by Type (2015-2020)
10.2 Global Biosimilar Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Biosimilar Drug Price by Type (2015-2020)
11 Global Biosimilar Drug Market Segment by Application
11.1 Global Biosimilar Drug Sales Market Share by Application (2015-2020)
11.2 Global Biosimilar Drug Revenue Market Share by Application (2015-2020)
11.3 Global Biosimilar Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biosimilar Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Biosimilar Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Biosimilar Drug Market Forecast (2021-2025)
12.2.2 Europe Biosimilar Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biosimilar Drug Market Forecast (2021-2025)
12.2.4 South America Biosimilar Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biosimilar Drug Market Forecast (2021-2025)
12.3 Biosimilar Drug Market Forecast by Type (2021-2025)
12.3.1 Global Biosimilar Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Biosimilar Drug Market Share Forecast by Type (2021-2025)
12.4 Biosimilar Drug Market Forecast by Application (2021-2025)
12.4.1 Global Biosimilar Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Biosimilar Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Biosimilar Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biosimilar Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biosimilar Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Biosimilar Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Biosimilar Drug Major Business
Table 10. Amgen Biosimilar Drug Total Revenue (USD Million) (2018-2019)
Table 11. Amgen SWOT Analysis
Table 12. Amgen Biosimilar Drug Product and Services
Table 13. Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. CP Guojian Pharma Basic Information, Manufacturing Base and Competitors
Table 15. CP Guojian Pharma Biosimilar Drug Major Business
Table 16. CP Guojian Pharma Biosimilar Drug Total Revenue (USD Million) (2018-2019)
Table 17. CP Guojian Pharma SWOT Analysis
Table 18. CP Guojian Pharma Biosimilar Drug Product and Services
Table 19. CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 21. Eli Lilly Biosimilar Drug Major Business
Table 22. Eli Lilly Biosimilar Drug Total Revenue (USD Million) (2018-2019)
Table 23. Eli Lilly SWOT Analysis
Table 24. Eli Lilly Biosimilar Drug Product and Services
Table 25. Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Novartis Basic Information, Manufacturing Base and Competitors
Table 27. Novartis Biosimilar Drug Major Business
Table 28. Novartis Biosimilar Drug Total Revenue (USD Million) (2018-2019)
Table 29. Novartis SWOT Analysis
Table 30. Novartis Biosimilar Drug Product and Services
Table 31. Novartis Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Biotech Pharma Basic Information, Manufacturing Base and Competitors
Table 33. Biotech Pharma Biosimilar Drug Major Business
Table 34. Biotech Pharma Biosimilar Drug Total Revenue (USD Million) (2018-2019)
Table 35. Biotech Pharma SWOT Analysis
Table 36. Biotech Pharma Biosimilar Drug Product and Services
Table 37. Biotech Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Global Biosimilar Drug Sales by Manufacturer (2018-2019) (K Dose)
Table 39. Global Biosimilar Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 40. Global Biosimilar Drug Sales by Regions (2015-2020) (K Dose)
Table 41. Global Biosimilar Drug Sales Market Share by Regions (2015-2020)
Table 42. Global Biosimilar Drug Revenue by Regions (2015-2020) (USD Million)
Table 43. North America Biosimilar Drug Sales by Countries (2015-2020) (K Dose)
Table 44. North America Biosimilar Drug Sales Market Share by Countries (2015-2020)
Table 45. North America Biosimilar Drug Revenue by Countries (2015-2020) (USD Million)
Table 46. North America Biosimilar Drug Revenue Market Share by Countries (2015-2020)
Table 47. Europe Biosimilar Drug Sales by Countries (2015-2020) (K Dose)
Table 48. Europe Biosimilar Drug Sales Market Share by Countries (2015-2020)
Table 49. Europe Biosimilar Drug Revenue by Countries (2015-2020) (USD Million)
Table 50. Asia-Pacific Biosimilar Drug Sales by Regions (2015-2020) (K Dose)
Table 51. Asia-Pacific Biosimilar Drug Sales Market Share by Regions (2015-2020)
Table 52. Asia-Pacific Biosimilar Drug Revenue by Regions (2015-2020) (USD Million)
Table 53. South America Biosimilar Drug Sales by Countries (2015-2020) (K Dose)
Table 54. South America Biosimilar Drug Sales Market Share by Countries (2015-2020)
Table 55. South America Biosimilar Drug Revenue by Countries (2015-2020) (USD Million)
Table 56. South America Biosimilar Drug Revenue Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Biosimilar Drug Sales by Countries (2015-2020) (K Dose)
Table 58. Middle East & Africa Biosimilar Drug Sales Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Biosimilar Drug Revenue by Countries (2015-2020) (USD Million)
Table 60. Middle East & Africa Biosimilar Drug Revenue Market Share by Countries (2015-2020)
Table 61. Global Biosimilar Drug Sales by Type (2015-2020) (K Dose)
Table 62. Global Biosimilar Drug Sales Share by Type (2015-2020)
Table 63. Global Biosimilar Drug Revenue by Type (2015-2020) (USD Million)
Table 64. Global Biosimilar Drug Revenue Share by Type (2015-2020)
Table 65. Global Biosimilar Drug Sales by Application (2015-2020) (K Dose)
Table 66. Global Biosimilar Drug Sales Share by Application (2015-2020)
Table 67. Global Biosimilar Drug Sales Forecast by Regions (2021-2025) (K Dose)
Table 68. Global Biosimilar Drug Market Share Forecast by Regions (2021-2025)
Table 69. Global Biosimilar Drug Sales Forecast by Type (2021-2025) (K Dose)
Table 70. Global Biosimilar Drug Market Share Forecast by Type (2021-2025)
Table 71. Global Biosimilar Drug Sales Forecast by Application (2021-2025)
Table 72. Global Biosimilar Drug Market Share Forecast by Application (2021-2025)
Table 73. Direct Channel Pros & Cons
Table 74. Indirect Channel Pros & Cons
Table 75. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biosimilar Drug Picture
Figure 2. Global Sales Market Share of Biosimilar Drug by Type in 2019
Figure 3. Injection Picture
Figure 4. Tablets Picture
Figure 5. Other Types Picture
Figure 6. Biosimilar Drug Sales Market Share by Application in 2019
Figure 7. Ankylosing Spondylitis Picture
Figure 8. Tumor Picture
Figure 9. Rheumatoid Arthrtis Picture
Figure 10. Cardiovascular Picture
Figure 11. Other Application Picture
Figure 12. Global Biosimilar Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Biosimilar Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Biosimilar Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Biosimilar Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Biosimilar Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Biosimilar Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 38. Global Biosimilar Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Biosimilar Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Biosimilar Drug Revenue Market Share by Regions in 2018
Figure 41. North America Biosimilar Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Biosimilar Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Biosimilar Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Biosimilar Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Biosimilar Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Biosimilar Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Biosimilar Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Biosimilar Drug Sales Market Share by Countries in 2018
Figure 49. North America Biosimilar Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Biosimilar Drug Revenue Market Share by Countries in 2018
Figure 51. United States Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 52. Canada Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 53. Mexico Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 54. Europe Biosimilar Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Biosimilar Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Biosimilar Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 58. UK Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 59. France Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 60. Russia Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 61. Italy Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 62. Asia-Pacific Biosimilar Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Biosimilar Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Biosimilar Drug Revenue Market Share by Regions 2019
Figure 65. China Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 66. Japan Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 67. Korea Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 68. India Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 69. Southeast Asia Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 70. South America Biosimilar Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Biosimilar Drug Sales Market Share by Countries in 2019
Figure 72. South America Biosimilar Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 74. Argentina Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 75. Middle East and Africa Biosimilar Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Biosimilar Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Biosimilar Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Biosimilar Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 80. Egypt Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 81. Turkey Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 82. South Africa Biosimilar Drug Sales and Growth Rate (2015-2020) (K Dose)
Figure 83. Global Biosimilar Drug Sales and Growth Rate (2021-2025) (K Dose)
Figure 84. Global Biosimilar Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Biosimilar Drug Market Forecast (2021-2025) (K Dose)
Figure 86. Europe Sales Biosimilar Drug Market Forecast (2021-2025) (K Dose)
Figure 87. Asia-Pacific Sales Biosimilar Drug Market Forecast (2021-2025) (K Dose)
Figure 88. South America Sales Biosimilar Drug Market Forecast (2021-2025) (K Dose)
Figure 89. Middle East & Africa Sales Biosimilar Drug Market Forecast (2021-2025) (K Dose)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
インターフェロンアルファ-2aバイオシミラーの世界市場 2020年 Market Overview The Interferon Alpha-2a Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…- ハーセプチンバイオシミラーの世界市場 2020年 Market Overview The global Herceptin Biosimilar market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Herceptin Biosimilar mar…
- 多関節若年性特発性関節炎薬の世界市場 2020年 Market Overview The global Polyarticular Juvenile Idiopathic Arthritis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …
- ベーチェット病治療薬の世界市場 2020年 Market Overview The global Behcet Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Behcet Disease Drug marke…
- 血管炎治療薬の世界市場 2020年 Market Overview The global Vasculitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vasculitis Drug market report…